EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Strategic Framework for Disease Classification: Leveraging Benefits and Costs in Multiclass Analysis

Shellyann Sooklal, Patrick Hosein

ACM Transactions on Computing for Healthcare · 31.01.2027 · 8 (1) · 1-33

DOI: 10.1145/3833381 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACM Transactions on Computing for Healthcare, online erschienen am 16.11.2026. Verfasst von Shellyann Sooklal und 1 weiteren Autor:innen. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Health datasets are often imbalanced, with a skew toward the healthy class, making traditional performance metrics like accuracy inadequate for evaluating minority class (disease-affected) predictions. Moreover, standard classifiers typically assume equal costs and benefits for decision outcomes, which is unsuitable for healthcare where misclassification implications vary. This article addresses these challenges by integrating cost–benefit considerations into both the training and evaluation of classifiers through a generalized, data-driven framework for deriving benefit and cost parameters based on clinical indicators such as survival probabilities, treatment outcomes, and healthcare expenditure. We propose modifications to Naive Bayes and Logistic Regression algorithms for multiclass classification and compare them against hierarchical and ensemble cost-sensitive algorithms, including Hierarchical Cost-Sensitive Kernel Logistic Regression (H-CSKLR), SAMME.C2, BAdaCost, and NP-MC. Experiments across fetal health, vertebral column, and hepatitis C datasets show that the proposed multiclass Benefit-Based Logistic Regression achieved the highest benefit values—17.96 for fetal health, 37.19 for vertebral column, and 4.80 for HCV—outperforming H-CSKLR (15.36, −12.54, and −3.44) and traditional accuracy-based Logistic Regression in most cases (19.01, 35.10, and 4.60). A Latin Hypercube Sampling-based sensitivity analysis further confirmed the robustness of the proposed framework across diverse benefit–cost configurations. These results highlight the transparency, stability, and clinical relevance of the approach.

Zitieren

APA

Sooklal, S., & Hosein, P. (2027). Strategic Framework for Disease Classification: Leveraging Benefits and Costs in Multiclass Analysis. ACM Transactions on Computing for Healthcare, 8(1), 1-33. https://doi.org/10.1145/3833381

Vancouver

Sooklal S, Hosein P. Strategic Framework for Disease Classification: Leveraging Benefits and Costs in Multiclass Analysis. ACM Transactions on Computing for Healthcare. 2027;8(1):1-33. doi:10.1145/3833381

BibTeX
@article{Sooklal2027,
  author = {Sooklal, Shellyann and Hosein, Patrick},
  title = {Strategic Framework for Disease Classification: Leveraging Benefits and Costs in Multiclass Analysis},
  journal = {ACM Transactions on Computing for Healthcare},
  year = {2027},
  volume = {8},
  number = {1},
  pages = {1--33},
  doi = {10.1145/3833381}
}
Kostenlos starten →